Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DELFLEX W DEXTROSE 3 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELFLEX W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DELFLEX W DEXTROSE 3 5 IN PLASTIC CONTAINER.
DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs DELFLEX W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Delflex with Dextrose 2.5% is a peritoneal dialysis solution that provides osmotic ultrafiltration and electrolyte replacement. Dextrose creates an osmotic gradient across the peritoneal membrane, promoting fluid removal. The solution corrects electrolyte imbalances and removes metabolic waste products via diffusion and convection.
Delflex with Dextrose 3.5% is a peritoneal dialysis solution that uses a high concentration of dextrose to create an osmotic gradient, drawing water and solutes from the blood across the peritoneal membrane into the dialysate, thereby removing excess fluid and waste products from the body. Dextrose is metabolized locally and systemically.
Intraperitoneal administration: 2-3 L per exchange, 4 exchanges per day, with dwell times of 4-6 hours; typical total volume 8-12 L daily.
Intraperitoneal administration: 2000 mL per exchange, typically 4 exchanges per day, with dwell times of 4-6 hours (CAPD) or cycler-adjusted for APD.
None Documented
None Documented
2 hours (peritoneal dwell time; systemic absorption minimal; continuous ambulatory peritoneal dialysis (CAPD) exchanges every 4-6 hours maintain steady state)
3-5 hours (prolonged in renal impairment; anuria up to 24-36 hours)
Renal: 100% (as unchanged drug in urine; no metabolism)
Renal: >90% unchanged drug; biliary/fecal: minimal (<5%)
Category C
Category C
Peritoneal dialysis solution
Peritoneal dialysis solution